Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography

Analytical Biochemistry

Volumn 266, Issue 2, 1999, Pages 216-221

  De Bruijn, Peter ^a   Verweij, Jaap ^a   Loos, Walter J ^a   Kolker, Herman J ^a   Planting, André S T ^a   Nooter, Kees ^a   Stoter, Gerrit ^a   Sparreboom, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; CALIBRATION; CHEMICALS REMOVAL (WATER TREATMENT); DISEASES; EFFLUENTS; GLYCOPROTEINS; METABOLITES; SULFUR COMPOUNDS; ZINC COMPOUNDS;

CALIBRATION GRAPHS; EMISSION WAVELENGTH; EXCITATION WAVELENGTH; FLUORESCENCE DETECTION; LIQUID CHROMATOGRAPHIC ASSAY; LOWER LIMITS OF QUANTITATIONS; PROTEIN PRECIPITATION; QUANTITATIVE EXTRACTION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

DOXORUBICIN; DOXORUBICINOL; GLYCOPROTEIN P;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; FLUORESCENCE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL;

EID: 0033555537     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1998.2943     Document Type: Article

References (24)

1. Arcamone F., Cassinelli G., Fantini G., Grein A., Orezzi P., Pol C., Spalla C. Biotechnol. Bioeng. 11:1969;1101-1110.
2. Booser D. J., Hortobagyi G. N. Drugs. 47:1994;223-258.
3. Speth P. A., Van Hoesel Q. G., Haanen C. Clin. Pharmacokinetics. 15:1988;15-31.
4. Kartner N., Riordan J. R., Ling V. Science. 221:1983;1285-1288.
5. Ford J. M., Hait W. N. Pharmacol. Rev. 42:1990;155-199.
6. Ozols R. F., Cunnion R. E., Klecker R. W., Hamilton T. C., Ostchega Y., Parillo J. F., Young R. C. J. Clin. Oncol. 5:1987;641-647.
7. Sonneveld P., Durie B. G., Lokhorst H. M., Marie J. P., Solbu G., Suciu G., Zittoun R., Lowenberg B., Nooter K. Lancet. 340:1992;255-259.
8. List A. F., Spier C., Greer J., Wolff S., Hutter J., Dorr R., Salmon S., Futscher B., Baier M., Dalton W. J. Clin. Oncol. 11:1993;1652-1660.
9. Erlichman C., Moore M., Thiessen J. J., Kerr I. G., Walker S., Goodman P., Bjarneson G., DeAngelis C., Bunting P. Cancer Res. 53:1993;4837-4842.
10. Bartlett N. L., Lum B. L., Fisher G. A., Brophy N. A., Ehsan M. N., Halsey J., Sikic B. I. J. Clin. Oncol. 12:1994;835-842.
11. Rushing D. A., Raber S. R., Rodvold K. A., Piscitelli S. C., Plank G. S., Tewskbury D. A. Cancer. 74:1994;834-841.
12. Giaccone G., Linn S. C., Welink J., Catimel G., Stieltjes H., Van der Vijgh W. J. F., Eeltink C., Vermorken J. B., Pinedo H. M. Clin. Cancer Res. 3:1997;2005-2015.
13. Hyafil F., Vergely C., Du Vignaud P., Grand-Perret T. Cancer Res. 53:1993;4595-4602.
14. Arcamone F., Lazatti M., Vicario G. P., Zini G. Cancer Chemother. Pharmacol. 12:1984;157-161.
15. Formelli F., Pollini C., Maria A., Di Marco A., Mariani A. Cancer Chemother. Pharmacol. 5:1972;139-144.
16. Yesair D. W., Schwartzbach E., Shuck D., Denine E. P., Asbell M. A. Cancer Res. 32:1972;1177-1181.
17. Riley C. A., Crom W. R., Evans W. E. Ther. Drug Monit. 7:1985;455-460.
18. El-Yazigi A., Al-Saleh I. J. Pharm. Sci. 74:1985;1225-1227.
19. Camaggi C. M., Comparsi R., Strocchi E., Testoni F., Pannuti F. Cancer Chemother. Pharmacol. 21:1988;216-220.
20. Mikan A., Martinez Lanao J., Gonzalez Lopez F., Dominguez-Gil Hurle A. Biomed. Chromatogr. 4:1990;154-156.
21. Beijnen J. H., Meenhorst P. L., Van Gijn R., Fromme M., Rosing H., Underberg W. J. M. J. Pharm. Biomed. Anal. 9:1991;995-1002.
22. Shah V. P., Midha K. K., Dighe S., McGilveray I. J., Skelly J. P., Yacobi A., Layloff T., Viswanathan C. T., Cook C. E., McDowall R. D., Pittman K. A., Spector S. J. Pharm. Sci. 81:1992;309-312.
23. Van der Vijgh W. J. F., Maessen P. A., Pinedo H. M. Cancer Chemother. Pharmacol. 26:1990;9-12.
24. Behnia K., Boroujerdi M. Cancer Chemother. Pharmacol. 41:1998;370-376.